MGMT and central nervous system cancer: Hence, subsequent studies can selectively incorporate significant clinical pathological features, radiomic features, surgical resection range, CNV, single-cell sequence features, immune microenvironment features like immune cell infiltration, immunotherapy-related variables like PD-L1 expression, and molecular features like MGMT methylation status into a nomogram for predicting the survival of glioma patients.